Artificial Intelligence (AI) in Inflammatory Bowel Disease Market (By Technology: Machine Learning, Natural Language Processing, Context-Aware Computing, Computer Vision; By End-User: Consumer Healthcare, Pharmaceutical Companies, Research And Development Sector; By IBD Type: Crohn’s Disease, Ulcerative Colitis; By Application: Diagnosis, Prognosis, Treatment, Monitoring ) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2025-2034
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Artificial Intelligence (AI) In Inflammatory Bowel Disease Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Artificial Intelligence (AI) In Inflammatory Bowel Disease Market, by Technology, 2023-2032
8.1.1. Machine Learning
8.1.1.1. Market Revenue and Forecast
8.1.2. Natural Language Processing
8.1.2.1. Market Revenue and Forecast
8.1.3. Context-Aware Computing
8.1.3.1. Market Revenue and Forecast
8.1.4. Computer Vision
8.1.4.1. Market Revenue and Forecast
9.1. Artificial Intelligence (AI) In Inflammatory Bowel Disease Market, by End-User, 2023-2032
9.1.1. Consumer Healthcare
9.1.1.1. Market Revenue and Forecast
9.1.2. Pharmaceutical Companies
9.1.2.1. Market Revenue and Forecast
9.1.3. Research And Development Sector
9.1.3.1. Market Revenue and Forecast
10.1. Artificial Intelligence (AI) In Inflammatory Bowel Disease Market, by IBD Type, 2023-2032
10.1.1. Crohn’s Disease
10.1.1.1. Market Revenue and Forecast
10.1.2. Ulcerative Colitis
10.1.2.1. Market Revenue and Forecast
11.1. Artificial Intelligence (AI) In Inflammatory Bowel Disease Market, by Application, 2023-2032
11.1.1. Diagnosis
11.1.1.1. Market Revenue and Forecast
11.1.2. Prognosis
11.1.2.1. Market Revenue and Forecast
11.1.3. Treatment
11.1.3.1. Market Revenue and Forecast
11.1.4. Monitoring
11.1.4.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Technology
12.1.2. Market Revenue and Forecast, by End-User
12.1.3. Market Revenue and Forecast, by IBD Type
12.1.4. Market Revenue and Forecast, by Application
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Technology
12.1.5.2. Market Revenue and Forecast, by End-User
12.1.5.3. Market Revenue and Forecast, by IBD Type
12.1.5.4. Market Revenue and Forecast, by Application
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Technology
12.1.6.2. Market Revenue and Forecast, by End-User
12.1.6.3. Market Revenue and Forecast, by IBD Type
12.1.6.4. Market Revenue and Forecast, by Application
12.2. Europe
12.2.1. Market Revenue and Forecast, by Technology
12.2.2. Market Revenue and Forecast, by End-User
12.2.3. Market Revenue and Forecast, by IBD Type
12.2.4. Market Revenue and Forecast, by Application
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Technology
12.2.5.2. Market Revenue and Forecast, by End-User
12.2.5.3. Market Revenue and Forecast, by IBD Type
12.2.5.4. Market Revenue and Forecast, by Application
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Technology
12.2.6.2. Market Revenue and Forecast, by End-User
12.2.6.3. Market Revenue and Forecast, by IBD Type
12.2.6.4. Market Revenue and Forecast, by Application
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Technology
12.2.7.2. Market Revenue and Forecast, by End-User
12.2.7.3. Market Revenue and Forecast, by IBD Type
12.2.7.4. Market Revenue and Forecast, by Application
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Technology
12.2.8.2. Market Revenue and Forecast, by End-User
12.2.8.3. Market Revenue and Forecast, by IBD Type
12.2.8.4. Market Revenue and Forecast, by Application
12.3. APAC
12.3.1. Market Revenue and Forecast, by Technology
12.3.2. Market Revenue and Forecast, by End-User
12.3.3. Market Revenue and Forecast, by IBD Type
12.3.4. Market Revenue and Forecast, by Application
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Technology
12.3.5.2. Market Revenue and Forecast, by End-User
12.3.5.3. Market Revenue and Forecast, by IBD Type
12.3.5.4. Market Revenue and Forecast, by Application
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Technology
12.3.6.2. Market Revenue and Forecast, by End-User
12.3.6.3. Market Revenue and Forecast, by IBD Type
12.3.6.4. Market Revenue and Forecast, by Application
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Technology
12.3.7.2. Market Revenue and Forecast, by End-User
12.3.7.3. Market Revenue and Forecast, by IBD Type
12.3.7.4. Market Revenue and Forecast, by Application
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Technology
12.3.8.2. Market Revenue and Forecast, by End-User
12.3.8.3. Market Revenue and Forecast, by IBD Type
12.3.8.4. Market Revenue and Forecast, by Application
12.4. MEA
12.4.1. Market Revenue and Forecast, by Technology
12.4.2. Market Revenue and Forecast, by End-User
12.4.3. Market Revenue and Forecast, by IBD Type
12.4.4. Market Revenue and Forecast, by Application
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Technology
12.4.5.2. Market Revenue and Forecast, by End-User
12.4.5.3. Market Revenue and Forecast, by IBD Type
12.4.5.4. Market Revenue and Forecast, by Application
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Technology
12.4.6.2. Market Revenue and Forecast, by End-User
12.4.6.3. Market Revenue and Forecast, by IBD Type
12.4.6.4. Market Revenue and Forecast, by Application
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Technology
12.4.7.2. Market Revenue and Forecast, by End-User
12.4.7.3. Market Revenue and Forecast, by IBD Type
12.4.7.4. Market Revenue and Forecast, by Application
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Technology
12.4.8.2. Market Revenue and Forecast, by End-User
12.4.8.3. Market Revenue and Forecast, by IBD Type
12.4.8.4. Market Revenue and Forecast, by Application
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Technology
12.5.2. Market Revenue and Forecast, by End-User
12.5.3. Market Revenue and Forecast, by IBD Type
12.5.4. Market Revenue and Forecast, by Application
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Technology
12.5.5.2. Market Revenue and Forecast, by End-User
12.5.5.3. Market Revenue and Forecast, by IBD Type
12.5.5.4. Market Revenue and Forecast, by Application
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Technology
12.5.6.2. Market Revenue and Forecast, by End-User
12.5.6.3. Market Revenue and Forecast, by IBD Type
12.5.6.4. Market Revenue and Forecast, by Application
13.1. IBM
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Google AI
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Microsoft
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. GE Healthcare
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Johnson & Johnson
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Philips Healthcare
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Nuance Communications
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Zebra Technologies
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Medtronic
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Boston Scientific
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample